Planta Med 2019; 85(09/10): 729-737
DOI: 10.1055/a-0902-5300
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Effects of Gut Microbiota and Ingredient-Ingredient Interaction on the Pharmacokinetic Properties of Rotundic Acid and Pedunculoside

Authors

  • Bao Yang

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Hui Li

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Qingfeng Ruan

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Shenxin Xuan

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Xiaojing Chen

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Hui Cui

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Zhongqiu Liu

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Jing Jin

    2   School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China
  • Zhongxiang Zhao

    1   School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China
Further Information

Publication History

received 27 January 2019
revised 17 April 2019

accepted 24 April 2019

Publication Date:
05 June 2019 (online)

Preview

Abstract

Rotundic acid and pedunculoside are the most abundant constituents in Ilicis Rotundae Cortex, and possess lipid-lowering activity. In this study, we evaluated the pharmacokinetic interactions of rotundic acid with pedunculoside and other ingredients from Ilicis Rotundae Cortex with rotundic acid and pedunculoside, and preliminarily investigated the effects of gut microbiota on their pharmacokinetics using a pseudo-germ-free rat model. After a single oral administration of each monomer, a monomer mixture, and Ilicis Rotundae Cortex extract to the conventional and pseudo-germ-free rats, rotundic acid and pedunculoside were quantified in plasma by an UPLC/Q-TOF-MS/MS method. The systemic exposure (maximum plasma concentration and area under concentration-time curve) of two analytes in conventional rats were increased in an approximately dose-dependent manner. Oral administration of rotundic acid and pedunculoside in the forms of a monomer mixture and Ilicis Rotundae Cortex extract to the conventional rats significantly decreased the systemic exposure compared with the monomer groups, which demonstrated the existence of significant pharmacokinetic interactions. The pseudo-germ-free rats were prepared by nonabsorbable antibiotic treatment, and the systemic exposure of two analytes were significantly decreased and most of the “time to reach the maximum” values were delayed in comparison to conventional rats, therefore gut microbiota might serve as an efficient absorption promoter. These results provide a scientific basis for the clinical application of the two bioactive constituents and Ilicis Rotundae Cortex.

Supporting Information